In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Arrow International Inc.

Division of Teleflex Inc.

Latest From Arrow International Inc.

FDA: Marketing Materials Encouraged Neurovascular Catheter Misuse

Some manufacturers may be suggesting their guide catheters can be used to remove thrombus – an off-label use that could cause hemorrhage and other adverse events, FDA says.

Neurology Regulation

Diagnostics A Bright Spot In Lackluster US Interventional Cardiology Market

The US Market for interventional cardiology products, which includes diagnostic and therapeutic products, is anticipated to expand from an estimated $3.3 billion in 2015 to roughly $3.6 billion in total product sales by the year 2020. One bright spot in this otherwise lackluster market is the interventional diagnostic products segment, which is projected to grow at CAGR of 4.7% and reach almost $1 billion by 2020, according to a report by Medtech Insight.

Medical Device Deals

Clarity For Celgene On Revlimid, A Backbone Of MM Treatment

Celgene reached a patent settlement with generic rival Natco that will allow entry of generic lenalidomide in March 2022, but only a limited quantity initially.

BioPharmaceutical Business Strategies

Multiple Myeloma Market Snapshot: New Drugs And Big Changes

The multiple myeloma treatment landscape is poised for a shakeup following the FDA approval of three new drugs to treat the incurable cancer, but with all the competition, determining which drugs to use when and in which patients won’t necessarily be straightforward.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teleflex Inc.
  • Senior Management
  • Philip B Fleck, Int. Pres. & CEO
    Frederick J Hirt, VP, Fin. & CFO
  • Contact Info
  • Arrow International Inc.
    Phone: (610) 378-0131
    2400 Bernville Rd.
    Reading, PA 19605